HomeCompareAYX vs CHD

AYX vs CHD: Dividend Comparison 2026

AYX yields 4.14% · CHD yields 1.27%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 CHD wins by $145.00 in total portfolio value· pulled ahead in Year 10
10 years
AYX
AYX
● Live price
4.14%
Share price
$48.26
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$26.2K
Annual income
$540.67
Full AYX calculator →
CHD
CHD
● Live price
1.27%
Share price
$93.91
Annual div
$1.19
5Y div CAGR
23.1%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$26.4K
Annual income
$1,292.51
Full CHD calculator →

Portfolio growth — AYX vs CHD

📍 CHD pulled ahead of the other in Year 10

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodAYXCHD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, AYX + CHD cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
AYX pays
CHD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

AYX
Annual income on $10K today (after 15% tax)
$352.26/yr
After 10yr DRIP, annual income (after tax)
$459.57/yr
CHD
Annual income on $10K today (after 15% tax)
$107.94/yr
After 10yr DRIP, annual income (after tax)
$1,098.63/yr
At 15% tax rate, CHD beats the other by $639.06/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of AYX + CHD for your $10,000?

AYX: 50%CHD: 50%
100% CHD50/50100% AYX
Portfolio after 10yr
$26.3K
Annual income
$916.58/yr
Blended yield
3.49%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on CHD right now

AYX
Analyst Ratings
14
Buy
11
Hold
Consensus: Buy
Price Target
$80.86
+67.6% upside vs current
Range: $50.00 — $125.00
Altman Z
1.2
Piotroski
4/9
CHD
Analyst Ratings
18
Buy
15
Hold
1
Sell
Consensus: Buy
Price Target
$98.40
+4.8% upside vs current
Range: $82.00 — $110.00
Altman Z
4.9
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

AYX buys
1
CHD buys
0
PoliticianChamberTickerTypeAmountDate
Daniel Goldman🏢 House$AYX▼ Sell$1,001 - $15,0002023-07-12
Ro Khanna🏢 House$AYX▼ Sell$1,001 - $15,0002022-12-06
Ro Khanna🏢 House$AYX▲ Buy$1,001 - $15,0002022-11-03
Ro Khanna🏢 House$AYX▼ Sell$1,001 - $15,0002022-01-21
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricAYXCHD
Forward yield4.14%1.27%
Annual dividend / share$2.00$1.19
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%23.1%
Portfolio after 10y$26.2K$26.4K
Annual income after 10y$540.67$1,292.51
Total dividends collected$4.8K$5.5K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples
Analyst consensusBuyBuy
Analyst price target$80.86$98.40

Year-by-year: AYX vs CHD ($10,000, DRIP)

YearAYX PortfolioAYX Income/yrCHD PortfolioCHD Income/yrGap
1$11,114$414.42$10,856$156.32+$258.00AYX
2$12,323$430.47$11,811$195.24+$512.00AYX
3$13,632$446.05$12,883$244.38+$749.00AYX
4$15,047$461.14$14,091$306.64+$956.00AYX
5$16,576$475.72$15,463$385.88+$1.1KAYX
6$18,226$489.78$17,033$487.17+$1.2KAYX
7$20,005$503.31$18,843$617.36+$1.2KAYX
8$21,922$516.30$20,947$785.72+$975.00AYX
9$23,985$528.75$23,419$1,004.91+$566.00AYX
10← crossover$26,205$540.67$26,350$1,292.51$145.00CHD

AYX vs CHD: Complete Analysis 2026

AYXStock

Alteryx, Inc. operates in analytic process automation business in the Asia-Pacific, Europe, the Middle East, Africa, Latin America, and internationally. The company's analytics platform enables organizations to enhance business outcomes and the productivity of their business analysts, data scientists, citizen data scientists, and data engineers. Its analytics platform comprises Alteryx Designer, a data profiling, preparation, blending, analytics, data science, and process automation product; Alteryx Server, a server-based product to manage, automate, and govern processes and applications in a web-based environment; Alteryx Intelligence Suite, an augmented machine learning, auto-modeling, and text mining product; Alteryx Connect, a collaborative data exploration platform; and Alteryx Promote, an analytics model management product for data scientists and analytics teams to build, manage, monitor, and deploy predictive models into real-time production applications. The company's platform also offers cloud-native products comprising Alteryx Designer Cloud, a browser-based version of Alteryx Designer product; Alteryx Machine Learning, an automated machine learning product to build, validate, iterate, and explore machine learning models; Alteryx Auto Insights, an analytics solution that automates insights for business users; and Alteryx Trifacta, an open and interactive cloud platform for data engineers and analysts to collaboratively profile, prepare, and pipeline data for analytics and machine learning. In addition, it provides technical support, instruction, and customer services. It serves retail, food services, consumer products, telecom and cable, media and entertainment, professional services, financial services, energy and utilities, public sector, manufacturing, travel and hospitality, healthcare and insurance, and technology industries. The company was founded in 1997 and is headquartered in Irvine, California.

Full AYX Calculator →

CHDConsumer Staples

Church & Dwight Co., Inc. develops, manufactures, and markets household, personal care, and specialty products. It operates through three segments: Consumer Domestic, Consumer International, and Specialty Products Division. The company offers cat litters, carpet deodorizers, laundry detergents, and baking soda, as well as other baking soda based products under the ARM & HAMMER brand; condoms, lubricants, and vibrators under the TROJAN brand; stain removers, cleaning solutions, laundry detergents, and bleach alternatives under the OXICLEAN brand; battery-operated and manual toothbrushes under the SPINBRUSH brand; home pregnancy and ovulation test kits under the FIRST RESPONSE brand; depilatories under the NAIR brand; oral analgesics under the ORAJEL brand; laundry detergents under the XTRA brand; gummy dietary supplements under the L'IL CRITTERS and VITAFUSION brands; dry shampoos under the BATISTE brand; water flossers and replacement showerheads under the WATERPIK brand; FLAWLESS products; cold shortening and relief products under the ZICAM brand; and oral care products under the THERABREATH brand. Its specialty products include animal productivity products, such as MEGALAC rumen bypass fat, a supplement that enables cows to maintain energy levels during the period of high milk production; BIO-CHLOR and FERMENTEN, which are used to reduce health issues associated with calving, as well as provides needed protein; and CELMANAX refined functional carbohydrate, a yeast-based prebiotic. The company offers sodium bicarbonate; and cleaning and deodorizing products. It sells its consumer products through supermarkets, mass merchandisers, wholesale clubs, drugstores, convenience stores, home stores, dollar and other discount stores, pet and other specialty stores, and websites and other e-commerce channels; and specialty products to industrial customers and livestock producers through distributors. The company was founded in 1846 and is headquartered in Ewing, New Jersey.

Full CHD Calculator →
📬

Get this AYX vs CHD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

AYX vs SCHDAYX vs JEPIAYX vs OAYX vs KOAYX vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.